Lemaitre Vascular (LMAT) Other Operating Expenses (2010 - 2026)

Lemaitre Vascular (LMAT) has 17 years of Other Operating Expenses data on file, last reported at $4.1 million in Q1 2026.

• On a quarterly basis, Other Operating Expenses fell 0.85% year-over-year to $4.1 million in Q1 2026; TTM through Mar 2026 was $33.0 million, a 47.44% increase from a year earlier, with the FY2025 full-year figure at $54.5 million, up 248.01% from the prior year.
• Other Operating Expenses for Q1 2026 stood at $4.1 million, down from $13.4 million in the prior quarter.
• Over the last five years, Other Operating Expenses for LMAT reached as high as $28.4 million in Q4 2023 and fell as low as $2.9 million in Q1 2022.
• Historically, Other Operating Expenses has averaged $9.5 million across 5 years, with a median of $8.2 million in 2022.
• Across the five-year window, Other Operating Expenses jumped 282.06% in 2023 and plunged 87.28% in 2024, its largest moves.
• Year by year, Other Operating Expenses stood at $23.2 million in 2022, then climbed by 22.68% to $28.4 million in 2023, then plunged by 87.28% to $3.6 million in 2024, then soared by 271.31% to $13.4 million in 2025, then slumped by 69.78% to $4.1 million in 2026.
• Per Business Quant data, the three most recent Other Operating Expenses figures were $4.1 million in Q1 2026, $13.4 million in Q4 2025, and $11.9 million in Q3 2025.